|
SFDA Proposes ‘Blacklist’ to Shame Drugmakers into Higher Standards
Stung by the chromium-contaminated drug capsule scandal, China’s State Food and Drug Administration (SFDA) is proposing to “blacklist” executives who oversee pharma companies found to produce substandard or counterfeit drugs.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives